Research review
Does lycopene help with cholesterol? What the research does and doesn't show
One older meta-analysis found lycopene and tomato products lowered LDL and total cholesterol; the largest, most recent pooled analysis of 34 randomized trials found no significant effect on cholesterol at all.
The lycopene-and-cholesterol evidence points two ways. An older meta-analysis found tomato and lycopene supplementation lowered LDL cholesterol by a measurable amount; the two largest, most recent pooled analyses — 43 studies and then 34 trials — found no significant difference in total cholesterol, LDL, HDL or triglycerides between lycopene and control groups.
What the evidence doesn't support
It doesn't support lycopene supplements as a dependable way to lower LDL or total cholesterol: the two largest, most recent meta-analyses, pooling 43 and 34 studies respectively, both found no significant difference between lycopene and control for any of the standard lipid markers. It doesn't support a specific dose, either — trials tested lycopene anywhere from about 1.4 to 75 mg a day, in forms ranging from tomato juice to synthetic capsules, and the researchers who pooled them flagged that variation as a likely reason the field's results conflict.
What the trials found
A 2017 meta-analysis pooled 21 randomized trials of tomato and lycopene supplementation against a range of cardiovascular markers. It found a significant reduction in LDL cholesterol (about 0.22 mmol/L) with tomato-product supplementation, along with a drop in one inflammatory marker (IL-6) and an improvement in a blood-vessel function measure. No other outcome the authors tracked, including HDL cholesterol and triglycerides, changed significantly.
A larger 2020 meta-analysis pooled 43 studies of dietary and supplemental lycopene, using doses that ranged from 1.44 to 75 mg a day across trials — with dose not even reported in a quarter of them. It found no significant difference between lycopene and control groups for total cholesterol, LDL, HDL or triglycerides, including in people who started with elevated levels. The authors described the field's findings as conflicting and pointed to the wide variation in dose and delivery form as a likely cause.
The most recent and largest analysis, from 2023, pooled 34 randomized trials testing lycopene and tomato products against cholesterol alongside blood pressure, blood sugar, body weight and inflammation markers. None of those measures, including cholesterol, changed significantly across the pooled trials.
| Study | Design | Population / dose | Finding |
|---|---|---|---|
| 2017 meta-analysis | 21 RCTs | Mixed adults, varied dose | LDL and IL-6 reduced; other markers unchanged |
| 2020 meta-analysis | 43 studies | 1.44–75 mg/day, varied form | No significant change in total cholesterol, LDL, HDL or triglycerides |
| 2023 meta-analysis | 34 RCTs | Mixed adults, varied dose | No significant change in cholesterol or other cardiovascular markers |
Questions people ask
Does lycopene lower LDL?
One 2017 meta-analysis of 21 trials found a significant LDL reduction with tomato-product supplementation. The two larger, more recent pooled analyses that followed it — 43 studies and then 34 trials — found no significant LDL difference between lycopene and control groups. The newer, larger body of evidence doesn't back a reliable LDL effect.
Is lycopene good for cholesterol?
The research is split, and the split runs by study size and recency: the smaller, older meta-analysis found a benefit; the two largest, newest ones found none. Given the disagreement, and the wide range of doses tested, nothing here supports treating lycopene as a dependable cholesterol intervention.
When to talk to a doctor
Anyone with elevated cholesterol, or on a prescribed lipid-lowering plan, should keep working with their doctor rather than relying on a supplement label. Lycopene is not a substitute for that care, and the conflicting evidence above doesn't support using it as one.
Related reading: lycopene and blood pressure, reviewed, lycopene: what the research does and doesn't show, and what is lycopene.
Sources
- The Effects of Lycopene and Tomato Consumption on Cardiovascular Risk Factors in Adults: A Grade Assessment Systematic Review and Meta-analysis A meta-analysis of 34 randomized trials found lycopene and tomato products had no significant effect on blood pressure, cholesterol, blood sugar, inflammation or body weight; the only significant change was in an oxidative-stress marker.
- Tomato and lycopene supplementation and cardiovascular risk factors: A systematic review and meta-analysis A meta-analysis of 21 randomized trials found tomato product supplementation significantly reduced LDL cholesterol and an inflammatory marker, but no other cardiovascular measure changed significantly.
- Effect of Dietary and Supplemental Lycopene on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis A meta-analysis of 43 studies found no significant difference between lycopene supplementation and control for total cholesterol, LDL, HDL or triglycerides, even in people who started with elevated levels; the authors noted highly variable doses and delivery forms across studies as a likely source of conflicting findings in the field.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.